Trusted brands in one place
Clinically proven for weight loss
Doctor-guided programs
No in-person appointments needed
Trusted brands in one place
Clinically proven for weight loss
Doctor-guided programs
No in-person appointments needed

Explore GLP-1's
News & Updates

Learn more about GLP'-1's latest news & updates

Explore By Category

All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
GLP-1 Compounding: What Patients Need to Know
News & Updates

GLP-1 Compounding: What Patients Need to Know

Compounded semaglutide and tirzepatide have helped millions of patients access GLP-1 medications at lower prices. But regulatory pressures are reshaping this market fast. Here's what you need to understand to protect your access and your wallet.

Read More
Generic Semaglutide: What Celon's Study Means for You
News & Updates

Generic Semaglutide: What Celon's Study Means for You

A Polish pharmaceutical company called Celon Pharma released early study data showing its generic semaglutide performs comparably to Ozempic. For patients paying out of pocket for GLP-1 medications, this development could eventually reshape the cost landscape significantly.

Read More
GLP-1 Self-Medication Risks You Need to Know
News & Updates

GLP-1 Self-Medication Risks You Need to Know

A Brazilian university study on GLP-1 self-medication reveals concerning patterns among adults using semaglutide and liraglutide for weight loss without a prescription. The findings raise important questions about safety, dosing, and what happens when these powerful medications are used outside a clinical setting. Here's what every GLP-1 patient needs to know.

Read More
Beyond GLP-1s: New Combo Therapies for Obesity
Science & How It Works

Beyond GLP-1s: New Combo Therapies for Obesity

GLP-1 medications like semaglutide and tirzepatide have changed obesity treatment, but the next generation goes even further. New combination hormone therapies are showing stronger weight loss results with potentially fewer side effects. Here is what patients and those considering treatment need to know.

Read More
Wegovy Pill: Novo's Lowest Dose Study Explained
News & Updates

Wegovy Pill: Novo's Lowest Dose Study Explained

Novo Nordisk has launched a new study to find the lowest effective dose for an oral version of Wegovy (semaglutide). This research could shape how millions of people access weight loss medication in pill form. Here's what patients need to know right now.

Read More
GLP-1 Microdosing: What It Is and Is It Safe?
Dosing & Usage

GLP-1 Microdosing: What It Is and Is It Safe?

GLP-1 microdosing is gaining attention as an alternative approach to standard dosing protocols for medications like semaglutide and tirzepatide. But is using smaller, off-label doses actually safer or more effective? Here's what the current evidence says and what patients should know before considering it.

Read More
Oral Wegovy Side Effects: What to Expect
Side Effects & Safety

Oral Wegovy Side Effects: What to Expect

Oral Wegovy brings the weight-loss benefits of semaglutide in pill form, but side effects are still part of the picture. This guide covers what you're likely to feel, what's rare but serious, and practical tips to manage symptoms so you can stay on track.

Read More
Ozempic and Sick Days: What the Research Shows
Health and Wellness

Ozempic and Sick Days: What the Research Shows

A growing body of research is examining whether starting Ozempic affects how often people take long-term sick leave from work. The findings have real implications for patients, employers, and health systems weighing the full value of GLP-1 therapy. Here's what you should know.

Read More
Exercise in a Pill? What Enveda's Drug Means for GLP-1 Users
Patient Guides

Exercise in a Pill? What Enveda's Drug Means for GLP-1 Users

A Colorado biotech called Enveda is reporting early results on a drug designed to help people maintain weight loss and preserve muscle after stopping GLP-1 medications. The compound targets leptin pathways and mimics some effects of physical exercise, though researchers are careful not to oversell it. Here's what GLP-1 users should know right now.

Read More